Chauncey Gardner-Johnson, Jr.

Safety

Age: 29
Free Agency: 2026 (UFA)
Accrued Seasons: 7
  • 2026 Salary Cap Charge: $0 (0.00% of cap)
  • 2026 Cash Payout: $0 (0.00% of spending)
  • 2026 Cash to Cap Ratio: 0
  • Contract Value: $1,170,000 ($1,170,000 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 105/197 at S

Current Contract

(SFA, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202528$1,170,000$650,0000.2%
Total$1,170,000$650,000

Contract Notes

Chauncey Gardner-Johnson signed a three year, $27 million contract with the Eagles. $10 million is fully guaranteed at signing including a $5.775 million roster bonus. There are multiple void years for salary cap purposes.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.2M
2025
Cash Due$1,170,000
Running Cash$1,170,000
Career Earnings: $28,852,835
Career APY: $4,121,834
Potential Earnings: $20,997,100
Total Guarantees: $28,074,200
Largest Cash Payment: $8,500,000 (2024)
Largest Cap Number: $4,500,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
SaintsDraftedTraded20194$3,307,100$826,775$787,100$2,807,10084.9%$935,700
EaglesDraftedExpired20194$3,307,100$826,775$787,100$2,540,00076.8%$2,540,000
LionsUFAExpired20231$6,500,000$6,500,000$6,500,000$6,500,000100.0%$6,500,000
EaglesUFATraded20243$27,000,000$9,000,000$10,000,000$8,500,00031.5%$8,500,000
TexansUFATerminated20243$27,000,000$9,000,000$10,000,000$00.0%$0
RavensPracticeTerminated20251$315,000$315,000$0$00.0%$0
BearsSFAActive20251$1,170,000$1,170,000$0$650,00055.6%$650,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Saints3$2,807,100$935,700$2,610,3250.0%$196,7750.0%
Eagles2$11,040,000$5,520,000$5,840,0000.0%$4,620,0000.0%
Lions1$6,500,000$6,500,000$4,500,0000.0%$2,000,0000.0%
Texans0$7,838,235$0$00.0%$8,250,0000.0%
Ravens0$17,500$0$00.0%$17,5000.0%
Bears1$650,000$650,000$650,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Saints$495,000$196,775$0$0$0$691,7750.4%$1,282,100
2020Saints$675,000$196,775$0$0$0$871,7750.4%$675,000
2021Saints$850,000$196,775$0$0$0$1,046,7750.6%$850,000
2022Eagles$2,540,000$0$0$0$0$2,540,0001.1%$2,540,000
2023Lions$2,500,000$2,000,000$0$0$2,500,000$4,500,0002.0%$6,500,000
2024Eagles$1,375,000$1,175,000$750,000$100,000$2,125,000$3,300,0001.3%$8,500,000
2025Bears$1,170,000$0$0$0$0$650,0000.2%$650,000
Total$9,605,000$3,765,325$750,000$100,000$4,625,000$13,600,325$20,997,100
Dead Money History
TeamYearCap ChargeCash Paid
Saints2022$196,775$0
Lions2024$2,000,000$0
Eagles2025$4,620,000$0
Texans2025$2,586,000$7,838,235
Ravens2025$17,500$17,500
Texans2026$5,664,000$0
Total$15,084,275$7,855,735

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
DefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201916051.0%40.7%0000000000000
202015082.3%32.1%5114165413100000
202112156.0%16.2%3214214447300000
202212065.9%0.2%616111528600000
20233017.1%0.2%16100003100000
202416086.7%0.2%3524002012601000
202513072.1%2.2%4620324564201000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$2,014,000$1,170,000
Injury Adjusted$2,014,000$1,170,000
test
OTC Valuation $2.4M $4.9M $7.3M $9.8M $12.2M APY $4.2M $8.4M $12.6M $16.7M $20.9M $5,549,000 $4,144,915

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.